Aastrom Biosciences, Inc. (ASTM) to Present at the Aegis Capital 2013 Healthcare Conference
9/19/2013 9:46:59 AM
ANN ARBOR, Mich., Sept. 19, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today announced that Nick Colangelo, President and CEO of Aastrom, will present at the Aegis Capital 2013 Healthcare Conference on Friday, September 27 at 9:00 a.m. PDT at The Encore at Wynn Las Vegas.
Help employers find you! Check out all the jobs and post your resume.
comments powered by